VERMOX cpr 500 mg 100 pce
7680388530233
CH-38853
P02CA01
1 / 3
google
Details
- Product number
- -
- CPT
- -
- Packaging group
- -
- Unit
- -
Articles (1)
Vermox 500 mg, Tabletten
Tabletten
100
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
mebendazolum
|
500.0 MG | Substance | Wirkstoff (Principe actif) |
|
lactosum monohydricum
|
34.0 MG | Substance | HNIDK |
|
methylcellulosum
|
- | Substance | HNIDK |
|
carboxymethylamylum natricum A
|
- | Substance | HNIDK |
|
natrium
|
2.23 MG | Substance | HBESI |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
maydis amylum
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
|
silica colloidalis anhydrica
|
- | Substance | HNIDK |
Authorization holder
JNTL Consumer Health II
6343 Risch
Authorization information
- Swissmedic authorization number
- 38853
- Drug name
- Vermox, Tabletten
- Galenic form
- TAB
- ATC Code
- P02CA01
- Authorization status
- Z
- Dispensation category
- D
- First authorization
- 18/12/1974
- Authorization expiration date
- 31/12/9999
- IT number
- 08.05.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- VERMOX cpr 500 mg 100 pce
- Description (DE)
- VERMOX Tabl 500 mg 100 Stk
- Market launch
- 20/09/1989
- Narcotic (BTM)
- No